Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology Strategy

11 Feb 2022

Abstract excerpt

Pulmonary fibrosis (PF) is a clinically common disease caused by many factors, which will lead to lung function decline and even respiratory failure. Jingyin granule has been confirmed to have anti-inflammatory and antiviral effects by former studies, and has been recommended for combating H1N1 influenza A virus (H1N1) infection and Coronavirus disease 2019 (COVID-19) in China. At present, studies have shown that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Lung Cancer Treatments and Mutations
Share to Quinazolinone synthesis and applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35222040
DOI: 10.3389/fphar.2022.825667

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology StrategyPMID 35222040Read ↗

Investigation of Anti-Epithelial-Mesenchymal Transition and Anti-Inflammation effects of Qing Fei Hua Xian Decotion on Pulmonary Fibrosis via Network Pharmacology and Experimental VerificationSemantic proximity Read ↗

Network pharmacology exploration reveals the bioactive compounds and molecular mechanisms by which Gui-Qi-Yang-Xin Decoction suppresses myocardial fibrosisSemantic proximity Read ↗

Network pharmacology-based identification of key pharmacological pathways of Yin–Huang–Qing–Fei capsule acting on chronic bronchitisSemantic proximity Read ↗

Mechanism of Protective Effect of Xuan-Bai-Cheng-Gi Decoction on LPS-Induced Acute Lung Injury Based on an Integrated Network Pharmacology and RNA-Sequencing ApproachSemantic proximity Read ↗

Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology.Semantic proximity Read ↗

A network pharmacology approach to determine the synergetic mechanisms of herb couple for treating rheumatic arthritisSemantic proximity Read ↗

Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacologySemantic proximity Read ↗

Combined transcriptomic and proteomic analysis reveals the mechanism of Xing-Qi-Huo-Xue granules on BLM-induced pulmonary fibrosis in ratsSemantic proximity Read ↗

Analyzing the Molecular Mechanism of Eucalyptol, Limonene and Pinene Enteric Capsules (QIENUO) in the Treatment of Pulmonary cystic fibrosis with Network Pharmacology and Verifying Molecular DockingSemantic proximity Read ↗

Network Pharmacology and Molecular Docking Reveal the Mechanism of Isodon Ternifolius (D. Don) Kudo Against Liver FibrosisSemantic proximity Read ↗

Molecular Basis for Treating COVID-19 with Official Chinese Herbal Formula LCTESemantic proximity Read ↗

Exploring the mechanisms of Shenmai injection against Chronic Obstructive Pulmonary Disease based on network pharmacology and molecular docking validationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.